505 related articles for article (PubMed ID: 24508523)
1. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells.
Ishima T; Fujita Y; Hashimoto K
Eur J Pharmacol; 2014 Mar; 727():167-73. PubMed ID: 24508523
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.
Nishimura T; Ishima T; Iyo M; Hashimoto K
PLoS One; 2008 Jul; 3(7):e2558. PubMed ID: 18596927
[TBL] [Abstract][Full Text] [Related]
3. Sertraline inhibits nerve growth factor-induced neurite outgrowth in PC12 cells via a mechanism involving the sigma-1 receptor.
Matsushima Y; Terada K; Kamei C; Sugimoto Y
Eur J Pharmacol; 2019 Jun; 853():129-135. PubMed ID: 30902656
[TBL] [Abstract][Full Text] [Related]
4. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.
Hashimoto K
Cent Nerv Syst Agents Med Chem; 2009 Sep; 9(3):197-204. PubMed ID: 20021354
[TBL] [Abstract][Full Text] [Related]
5. Sigma-1 Receptor Agonists and Their Clinical Implications in Neuropsychiatric Disorders.
Albayrak Y; Hashimoto K
Adv Exp Med Biol; 2017; 964():153-161. PubMed ID: 28315270
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluvoxamine on nerve growth factor-induced neurite outgrowth inhibition by dexamethasone in PC12 cells.
Matsushima Y; Terada K; Takata J; Karube Y; Kamei C; Sugimoto Y
Biosci Biotechnol Biochem; 2019 Apr; 83(4):659-665. PubMed ID: 30543144
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors.
Ishima T; Nishimura T; Iyo M; Hashimoto K
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1656-9. PubMed ID: 18647636
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.
Ishima T; Hashimoto K
PLoS One; 2012; 7(5):e37989. PubMed ID: 22655093
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo.
Robson MJ; Elliott M; Seminerio MJ; Matsumoto RR
Eur Neuropsychopharmacol; 2012 Apr; 22(4):308-17. PubMed ID: 21911285
[TBL] [Abstract][Full Text] [Related]
10. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Sánchez C; Meier E
Psychopharmacology (Berl); 1997 Feb; 129(3):197-205. PubMed ID: 9084057
[TBL] [Abstract][Full Text] [Related]
11. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants.
Takebayashi M; Hayashi T; Su TP
J Pharmacol Exp Ther; 2002 Dec; 303(3):1227-37. PubMed ID: 12438547
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
14. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
Bermack JE; Haddjeri N; Debonnel G
J Pharmacol Exp Ther; 2004 Aug; 310(2):578-83. PubMed ID: 15044555
[TBL] [Abstract][Full Text] [Related]
15. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interaction with the sigma1 (σ1)-receptor in the acute behavioral effects of antidepressants.
Villard V; Meunier J; Chevallier N; Maurice T
J Pharmacol Sci; 2011; 115(3):279-92. PubMed ID: 21427517
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
Ishima T; Futamura T; Ohgi Y; Yoshimi N; Kikuchi T; Hashimoto K
Eur Neuropsychopharmacol; 2015 Apr; 25(4):505-11. PubMed ID: 25687838
[TBL] [Abstract][Full Text] [Related]
18. Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain.
Narita N; Hashimoto K; Tomitaka S; Minabe Y
Eur J Pharmacol; 1996 Jun; 307(1):117-9. PubMed ID: 8831113
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
Rogóz Z; Skuza G
Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
